TABLE 2.
Cox regression analysis of mRNASig and OS of ccRCC in the training cohort.
Variables | Univariate analysis | Multivariate analysis | ||
HR (95% CI) | P | HR (95% CI) | P | |
Age | 1.08 (1.01–1.05) | 0.002 | 1.04 (1.01–1.06) | 0.005 |
T stage | ||||
T1 | Ref | |||
T2 | 1.53 (0.74–3.14) | 0.2 | ||
T3 | 2.7 (1.61–4.45) | <0.001 | ||
T4 | 9.79 (3.70–25.89) | <0.001 | ||
N Stage | ||||
N0 | Ref | |||
N1 | 5.72 (2.42–13.52) | <0.001 | ||
NX | 0.69 (0.43–1.10) | 0.2 | ||
M Stage | ||||
M0 | Ref | |||
M1 | 4.67 (2.98–7.29) | <0.001 | ||
MX | 0.56 (0.076–4.08) | 0.6 | ||
AJCC Stage | ||||
Stage I | Ref | |||
Stage II | 0.90 (0.34–2.41) | 0.8 | 0.85 (0.31–2.27) | 0.7 |
Stage III | 2.0 (1.10–3.65) | 0.02 | 1.22 (0.65–2.28) | 0.5 |
Stage IV | 6.28 (3.64–10.84) | <0.001 | 4.32 (2.43–7.70) | <0.001 |
Grade | ||||
G1 and G2 | Ref | |||
G3 and G4 | 2.94 (1.79–4.84) | <0.001 | 2.24 (1.33–3.77) | 0.002 |
Risk score | ||||
Low | Ref | |||
High | 2.73 (1.71–4.35) | <0.001 | 2.49 (1.52–4.05) | <0.001 |